From: Exploring the role and function of trial steering committees: results of an expert panel meeting
1. | Title of trial |
2. | Funding source(s) and Grant No. |
3. | Sample size sought |
4. | Protocol amendments and sub-studies |
5. | Summary of the data monitoring committee (DMC) recommendations |
6. | Date recruitment started |
7. | Proposed date for recruitment end |
8. | Actual recruitment rate versus target rate (by month/quarter) |
9. | Acceptance rate as a proportion of the following: |
Ā | i) those invited to participate, and |
Ā | ii) if known, all eligible participants |
10. | Percentage of participants proceeding through each trial stage to allow monitoring of the recruitment and retention, including missing outcome data. Not split by treatment/intervention arms. |
11. | Quarterly/monthly forecasts of recruitment for the planned remainder of the trial |
12. | Losses to follow-up as follows: |
Ā | i) as a proportion of those entered, and |
Ā | ii) per month/quarter |
13. | Data management metrics: rate of returns, volume of queries, time to return, enhanced metrics via electronic data capture |
14. | Number for whom follow-up has been completed successfully (or still being successfully followed-up) |
15. | Overall withdrawal rate and level of withdrawal summarising those patients who have withdrawn from treatment but are still in follow-up and those who withdraw with no future contact. |
16. | Summary of adherence to treatment/intervention. Not split by treatment/intervention arms. |
17. | Summary of adverse events including type, for example, adverse events, serious adverse events and suspected unexpected serious adverse reactions |
18. | Completeness of data collected |
19. | Any available results (pooled) |
20. | Summary of protocol deviations overall and by site |
21. | Any organisational problems or other trial issues |
22. | Issues specific to individual trials (to be specified by the Steering Committee) |